1,050 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
JNJ Johnson & Johnson $139.96 $375.48B Uptrend
Article Searches
Roche Extends Offer Period for Spark Therapeutics Acquisition http://www.zacks.com/stock/news/370066/roche-extends-offer-period-for-spark-therapeutics-acquisition?cid=CS-ZC-FT-370066 Apr 03, 2019 - Roche (RHHBY) withdraws its Premerger Notification and Report Form in connection with the pending acquisition of Spark Therapeutics.
Novartis Gets Approval for Psoriasis Drug Cosentyx in China http://www.zacks.com/stock/news/369420/novartis-gets-approval-for-psoriasis-drug-cosentyx-in-china?cid=CS-ZC-FT-369420 Apr 02, 2019 - Novartis' (NVS) psoriasis drug gets approval in China. The company also signs an agreement to expand its biologics therapy manufacturing capability.
Company News For Apr 2, 2019 http://www.zacks.com/stock/news/369195/company-news-for-apr-2-2019?cid=CS-ZC--369195 Apr 02, 2019 - Companies in the news are: JNJ, SCOR, VFF and TGTX
Spero Gets Fast Track Designation for SPR994, Shares Improve http://www.zacks.com/stock/news/368643/spero-gets-fast-track-designation-for-spr994-shares-improve?cid=CS-ZC-FT-368643 Apr 01, 2019 - Spero???s (SPRO) SPR994 receives Fast Track designation by the FDA for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis.
3 Big Pharma Stocks to Add to Your Portfolio This April http://www.zacks.com/stock/news/368171/3-big-pharma-stocks-to-add-to-your-portfolio-this-april?cid=CS-ZC-FT-368171 Apr 01, 2019 - The large-cap pharma industry is on a strong footing in 2019. Here are three stocks from the space that investors may consider betting on.
Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug Approvals http://www.zacks.com/stock/news/367176/pharma-stock-roundup-azn-inks-cancer-deal-abbv-nvs-others-get-drug-approvals?cid=CS-ZC-FT-367176 Mar 29, 2019 - AstraZeneca announces a $6.9 billion cancer deal with Daiichi Sankyo. AbbVie (ABBV), Novartis (NVS) & AstraZeneca's (AZN) drugs get regulatory approvals.
Dow 30 Stock Roundup: Apple Launches New Services, JPMorgan to Trim Wealth Jobs http://www.zacks.com/stock/news/366674/dow-30-stock-roundup-apple-launches-new-services-jpmorgan-to-trim-wealth-jobs?cid=CS-ZC-FT-366674 Mar 29, 2019 - The index enjoyed quite a positive week even as a yield curve inversion weighed on broader markets.
AstraZeneca's Forxiga Gets Nod in Japan for Type I Diabetes http://www.zacks.com/stock/news/366338/astrazenecas-forxiga-gets-nod-in-japan-for-type-i-diabetes?cid=CS-ZC-FT-366338 Mar 28, 2019 - AstraZeneca's (AZN) Forxiga gets approval in Japan for type I diabetes.
J&J Files sBLA for Darzalex in Expanded Myeloma Patient Group http://www.zacks.com/stock/news/365606/jj-files-sbla-for-darzalex-in-expanded-myeloma-patient-group?cid=CS-ZC-FT-365606 Mar 27, 2019 - J&J (JNJ) submits sBLA seeking approval for Darzalex combination regimen in newly-diagnosed, transplant eligible multiple myeloma patient population
Bayer & JNJ Settle Numerous Xarelto Lawsuits for $775 Million http://www.zacks.com/stock/news/364998/bayer-jnj-settle-numerous-xarelto-lawsuits-for-%24775-million?cid=CS-ZC-FT-364998 Mar 26, 2019 - Bayer (BAYRY) and partner Johnson & Johnson settle about 25,000 claims over blood thinner, Xarelto for $775 million.

Pages: 123456789...105

<<<Page 4>